{"id":"doi:10.1038/s41587-026-03018-2","kind":"review","title":"The promises and challenges of neoantigen cancer vaccines","authors":["Patrick Alexander Ott"],"author_count":1,"year":2026,"published":"2026-03-10","venue":"Nature Biotechnology","cited_by":10,"doi":"10.1038/s41587-026-03018-2","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41587-026-03018-2","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41587-026-03018-2","updated":null,"pmid":"41807825","pmcid":null,"openalex_id":"W7134966475","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"peer_reviewed":null,"categories":["Immunotherapy and Immune Responses"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"mrna-cancer-vaccines","name":"mRNA Therapeutics & Cancer Vaccines","domain_slug":"medicine"}],"cited_in_dossiers":[]}